Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma

Onkologie
Volker Bartsch

Abstract

The development of an oral formulation of vinorelbine (Navelbine softgelatine capsules, Pierre Fabre Pharma, Freiburg i.Br., Germany) represents a significant advance in the treatment of patients with cancer. Oral chemotherapy is more convenient for the patients and brings significant time savings. Vinorelbine is rapidly absorbed after oral ingestion. The bioavailability is in the range of 33 to 43% and is not affected by concomitant food intake or by vomiting occuring 1.5 h or later after dosing. No significant differences in the pharmacokinetics of oral vinorelbine were observed between elderly (> or =70 years) and younger patients. The recommended dose schedule for oral vinorelbine is 60 mg/m(2) weekly for the initial 3 weeks (cycle 1) and 80 mg/m(2) weekly thereafter. However, if severe neutropenia is encountered during the first cycle, treatment is continued with weekly doses of 60 mg/m(2). Bioavailability studies have demonstrated that oral vinorelbine doses of 60 and 80 mg/m(2) are comparable to intravenous doses of 25 and 30 mg/m(2), respectively. Several clinical studies have demonstrated that the new oral formulation of vinorelbine can be safely administered, even to elderly patients, and is comparable in activity to ...Continue Reading

References

Jan 1, 1991·Cancer Chemotherapy and Pharmacology·X J ZhouR Rahmani
Oct 15, 1987·Biochemical Pharmacology·D EssassiJ P Tillement
Jan 1, 1984·Pharmacology·E AlbengresJ P Tillement
Jan 1, 1995·Investigational New Drugs·D J Adams, V C Knick
Oct 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S JonesJ Hohneker
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E K RowinskyD S Ettinger
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·D LevêqueF Jehl
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·S UrienJ P Tillement
Jan 1, 1996·Breast Cancer Research and Treatment·M TerenzianiG Bonadonna
Nov 6, 1996·Journal of the National Cancer Institute·G V KornekW Scheithauer
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G LiuE Warner
Jul 28, 2001·American Journal of Clinical Oncology·T D LongT O'Donnell
Jan 5, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J JassemA Depierr
Feb 2, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MartyC Puozzo
Feb 15, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A DepierreV Trillet-Lenoir
Feb 15, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BonneterreM Piccart
Feb 21, 2002·Journal of the National Cancer Institute·Scott D RamseyDavid R Gandara
Oct 3, 2002·Cancer Chemotherapy and Pharmacology·Roland BugatIsabelle Senac
Oct 22, 2002·European Journal of Clinical Pharmacology·Philippe VariolChristian Puozzo
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G V ScagliottiUNKNOWN Italian Lung Cancer Project
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Robert L ShepardAnne H Dantzig
Mar 6, 2003·Journal of the National Cancer Institute·Paul A Bunn, Rogerio Lilenbaum
Oct 29, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J JassemF Lefresne
Feb 18, 2004·Clinical Lung Cancer·Christian Puozzo, Cesare Gridelli
May 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M E R O'BrienF Lefresne
May 26, 2004·Cancer Chemotherapy and Pharmacology·David KhayatChristian Puozzo
Jun 2, 2004·Nature Reviews. Cancer·Robert S Kerbel, Barton A Kamen
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bent EjlertsenUNKNOWN Scandinavian Breast Group Trial (SBG9403
Nov 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C GridelliF De Marinis
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A WeltU Vanhoefer
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A MartoniL Mantovani
Feb 17, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yuh-Min ChenJacqueline Whang-Peng
Mar 12, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·T De PasF de Braud
Mar 22, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·M De LenaJ Gasmi
Jun 24, 2005·The New England Journal of Medicine·Timothy WintonUNKNOWN National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators

❮ Previous
Next ❯

Citations

Mar 15, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Steffen Filskov SorensenPeter Meldgaard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
J Y DouillardG Scagliotti
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
P BerthaudT Tursz
© 2021 Meta ULC. All rights reserved